Quadriceps Muscle Contractile Properties and Functional Performance

January 13, 2023 updated by: Menan Aliy Eldeen Mohamed Elmahdy, Cairo University

Correlation Between Contractile Properties of Quadriceps Muscle and Functional Performance in Runners With Patellofemoral Pain Syndrome

The aim of this study is to investigate the association between tensiomyography parameters (from rectus femoris, vastus lateralis and vastus medialis) and functional abilities in runners with patellofemoral pain syndrome.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Running is one of the most widespread activities during which overuse injuries of the lower extremity occur. Long-distance running is very popular among participants of recreational sports . In 2008, about 11.5% of the population in the United States ran and, of this group, 3.4% ran on average two times a week or more. In Europe, it is estimated that 36% of the population aged 15-65 years are recreational runners.

Most running-related injuries occur in the lower extremities. The most common anatomical site of running injuries is the knee.

Risk factors for running injuries have been well investigated , However, because of the heterogeneity of the studies (e.g., definition of injury, recreational or elite runners, and short- or long-distance runners), no clear overview is available regarding the most important risk factors for running injuries. Increased training volume per week in male runners, and a history of previous injuries for runners, are known significant risk factors for running injuries.

The various purported risk factors for running injuries are commonly divided into intrinsic and extrinsic risk factors. Intrinsic risk factors include mostly anatomic and other variables that are innate to the individual, such as gender, age, height, weight, personality type (e.g., aggressive, passive), and anatomic factors such as femoral anteversion, genu varus or valgus, pes planus or cavus, bone density, muscular flexibility, and leg-length discrepancies. Extrinsic risk factors include training variables such as mileage, hill running, pace, interval training, equipment (shoes, shoe inserts), and training surfaces.

Patellofemoral pain syndrome is the most common overuse injury of the lower extremity, and is particularly prevalent in those who are physically active. For example, approximately 2.5 million runners will be diagnosed with PFPS in a given year. PFPS also is a significant problem in the military as it has been reported that 37% of recruits develop PFPS while in basic combat training. Females are reported to be at greater risks for PFPS than their male counterparts. Alarmingly, 70% to 90% of individuals with PFPS have recurrent or chronic pain, In addition, the result of a recent study suggest that having PFPS as a younger individual may predispose one to develop patellofemoral osteoarthritis later in life.

One of the most common risk factors of patellofemoral pain syndrome is the imbalance of the quadriceps musculature and maltracking of the patella are 2 potential factors that may lead to PFP.

The nature of PFP is multifactorial, and many risk factors have been associated with this condition. This come in agreement with several authors who reported that patellofemoral pain syndrome is one of the most common injuries in runners.

Study Type

Observational

Enrollment (Actual)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • El-Sheikh Zayed City, Egypt
        • Haven Health care

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 30 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

30 Distance runners selected from Egyptian clubs will participate in the study.

Description

Inclusion Criteria:

  • The athletes age range between 18-30 years old will participate in this study.
  • Both males and females will participate in this study.
  • All athletes will be selected from long-distance runners.
  • All athletes have an average running period (6 days per week and 5 hours per day).

Exclusion Criteria:

  • Athletes with foot deformities such as hallux valgus, foot supination, pes planus, and pes cavus,
  • Athletes with biomechanical abnormalities and complications affecting walking ability and performance.
  • History of lower limbs or back surgery or injury.
  • Structural or functional leg length discrepancy.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Cross-Sectional

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Study Group

Athletes with patellofemoral pain syndrome will be selected Muscle contractile properties and functional performance will be assessed for athletes with patellofemoral pain syndrome .

Data will be collected from all athletes regarding age, gender, training intensity running experience and previous injuries.

By the end of the assessment it will be detected if muscle contractile properties of vastus medialis and vastus lateralis is a determinant factor that influence functional performance in runners with patellofemoral pain syndrome.

Quadriceps muscle contractile properties will be assessed using tensiomayography

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Contractile properties of Quadriceps muscle for 30 runners with patellofemoral pain syndrome
Time Frame: measured at the baseline as it is a cross sectional study
Will be assessed using Tensiomayography
measured at the baseline as it is a cross sectional study
Anteromedial lunge Functional Performance Test designed for 30 runners with patellofemoral pain syndrome
Time Frame: measured at the baseline as it is a cross sectional study
Anteromedial lunge test will be performed by each athlete for 3 trails with a 3 min recovery period between .
measured at the baseline as it is a cross sectional study
Step-down Functional Performance Test designed for 30 runners with patellofemoral pain syndrome
Time Frame: measured at the baseline as it is a cross sectional study
Step-down test will be performed by each athlete for 3 trails with a 3 min recovery
measured at the baseline as it is a cross sectional study
Balance and reach Functional Performance Test designed for 30 runners with patellofemoral pain syndrome
Time Frame: measured at the baseline as it is a cross sectional study
Balance and reach test will be performed by each athlete for 3 trails with a 3 min recovery
measured at the baseline as it is a cross sectional study

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: kahled ayad, Prof, Professor of Orthopaedic Physical Therapy, Deraya University and Cairo University, Egypt

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 20, 2022

Primary Completion (Actual)

September 20, 2022

Study Completion (Actual)

January 1, 2023

Study Registration Dates

First Submitted

April 13, 2022

First Submitted That Met QC Criteria

April 21, 2022

First Posted (Actual)

April 27, 2022

Study Record Updates

Last Update Posted (Estimate)

January 16, 2023

Last Update Submitted That Met QC Criteria

January 13, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • P.T.REC/012/003382

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Patellofemoral Pain Syndrome

Clinical Trials on Tensiomayography (TMG)

Subscribe